<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2017-05-10" version="184">
<accession>Q9Y243</accession>
<accession>Q0VAA6</accession>
<accession>Q5VTI1</accession>
<accession>Q5VTI2</accession>
<accession>Q96QV3</accession>
<accession>Q9UFP5</accession>
<name>AKT3_HUMAN</name>
<protein>
<recommendedName>
<fullName>RAC-gamma serine/threonine-protein kinase</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Protein kinase Akt-3</fullName>
</alternativeName>
<alternativeName>
<fullName>Protein kinase B gamma</fullName>
<shortName>PKB gamma</shortName>
</alternativeName>
<alternativeName>
<fullName>RAC-PK-gamma</fullName>
</alternativeName>
<alternativeName>
<fullName>STK-2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">AKT3</name>
<name type="synonym">PKBG</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="9133" last="9136">
<title>A human protein kinase B gamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain.</title>
<authorList>
<person name="Brodbeck D."/>
<person name="Cron P."/>
<person name="Hemmings B.A."/>
</authorList>
<dbReference type="PubMed" id="10092583"/>
<dbReference type="DOI" id="10.1074/jbc.274.14.9133"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>MUTAGENESIS</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="257" first="906" last="910">
<title>Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site.</title>
<authorList>
<person name="Nakatani K."/>
<person name="Sakaue H."/>
<person name="Thompson D.A."/>
<person name="Weigel R.J."/>
<person name="Roth R.A."/>
</authorList>
<dbReference type="PubMed" id="10208883"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0559"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Eur. J. Biochem." volume="265" first="353" last="360">
<title>Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3.</title>
<authorList>
<person name="Masure S."/>
<person name="Haefner B."/>
<person name="Wesselink J.-J."/>
<person name="Hoefnagel E."/>
<person name="Mortier E."/>
<person name="Verhasselt P."/>
<person name="Tuytelaars A."/>
<person name="Gordon R."/>
<person name="Richardson A."/>
</authorList>
<dbReference type="PubMed" id="10491192"/>
<dbReference type="DOI" id="10.1046/j.1432-1327.1999.00774.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="1998-08" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of a novel human cDNA, STK-2, which encodes a rat serine-threonine protein kinase (STK) homolog.</title>
<authorList>
<person name="Li X."/>
<person name="Yu L."/>
<person name="Huang H."/>
<person name="Zhang M."/>
<person name="Zhao Y."/>
<person name="Zhao S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2001" name="Genome Res." volume="11" first="422" last="435">
<title>Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.</title>
<authorList>
<person name="Wiemann S."/>
<person name="Weil B."/>
<person name="Wellenreuther R."/>
<person name="Gassenhuber J."/>
<person name="Glassl S."/>
<person name="Ansorge W."/>
<person name="Boecher M."/>
<person name="Bloecker H."/>
<person name="Bauersachs S."/>
<person name="Blum H."/>
<person name="Lauber J."/>
<person name="Duesterhoeft A."/>
<person name="Beyer A."/>
<person name="Koehrer K."/>
<person name="Strack N."/>
<person name="Mewes H.-W."/>
<person name="Ottenwaelder B."/>
<person name="Obermaier B."/>
<person name="Tampe J."/>
<person name="Heubner D."/>
<person name="Wambutt R."/>
<person name="Korn B."/>
<person name="Klein M."/>
<person name="Poustka A."/>
</authorList>
<dbReference type="PubMed" id="11230166"/>
<dbReference type="DOI" id="10.1101/gr.GR1547R"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="29550" last="29558">
<title>Two splice variants of PKB gamma have different regulatory capacity depending on the presence or absence of the regulatory phosphorylation site Ser-472 in the C-terminal hydrophobic domain.</title>
<authorList>
<person name="Brodbeck D."/>
<person name="Hill M.M."/>
<person name="Hemmings B.A."/>
</authorList>
<dbReference type="PubMed" id="11387345"/>
<dbReference type="DOI" id="10.1074/jbc.M104633200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2)</scope>
<scope>MUTAGENESIS OF THR-305 AND THR-447</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1998" name="Biochem. J." volume="331" first="299" last="308">
<title>Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha.</title>
<authorList>
<person name="Walker K.S."/>
<person name="Deak M."/>
<person name="Paterson A."/>
<person name="Hudson K."/>
<person name="Cohen P."/>
<person name="Alessi D.R."/>
</authorList>
<dbReference type="PubMed" id="9512493"/>
<dbReference type="DOI" id="10.1042/bj3310299"/>
</citation>
<scope>CHARACTERIZATION</scope>
<scope>PHOSPHORYLATION AT THR-305 BY PDPK1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="Biochemistry" volume="41" first="10351" last="10359">
<title>Characterization of PDK2 activity against protein kinase B gamma.</title>
<authorList>
<person name="Hodgkinson C.P."/>
<person name="Sale E.M."/>
<person name="Sale G.J."/>
</authorList>
<dbReference type="PubMed" id="12162751"/>
<dbReference type="DOI" id="10.1021/bi026065r"/>
</citation>
<scope>PHOSPHORYLATION AT SER-472</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="3743" last="3751">
<title>Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family.</title>
<authorList>
<person name="Laine J."/>
<person name="Kuenstle G."/>
<person name="Obata T."/>
<person name="Noguchi M."/>
</authorList>
<dbReference type="PubMed" id="11707444"/>
<dbReference type="DOI" id="10.1074/jbc.M107069200"/>
</citation>
<scope>INTERACTION WITH TCL1A</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="1513" last="1525">
<title>Identification of Akt association and oligomerization domains of the Akt kinase coactivator TCL1.</title>
<authorList>
<person name="Kuenstle G."/>
<person name="Laine J."/>
<person name="Pierron G."/>
<person name="Kagami S."/>
<person name="Nakajima H."/>
<person name="Hoh F."/>
<person name="Roumestand C."/>
<person name="Stern M.H."/>
<person name="Noguchi M."/>
</authorList>
<dbReference type="PubMed" id="11839817"/>
<dbReference type="DOI" id="10.1128/MCB.22.5.1513-1525.2002"/>
</citation>
<scope>INTERACTION WITH TCL1A</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="Cancer Res." volume="64" first="7002" last="7010">
<title>Deregulated Akt3 activity promotes development of malignant melanoma.</title>
<authorList>
<person name="Stahl J.M."/>
<person name="Sharma A."/>
<person name="Cheung M."/>
<person name="Zimmerman M."/>
<person name="Cheng J.Q."/>
<person name="Bosenberg M.W."/>
<person name="Kester M."/>
<person name="Sandirasegarane L."/>
<person name="Robertson G.P."/>
</authorList>
<dbReference type="PubMed" id="15466193"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-04-1399"/>
</citation>
<scope>INVOLVEMENT IN TUMORS</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Cancer Res." volume="66" first="11718" last="11725">
<title>A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition.</title>
<authorList>
<person name="Cristiano B.E."/>
<person name="Chan J.C."/>
<person name="Hannan K.M."/>
<person name="Lundie N.A."/>
<person name="Marmy-Conus N.J."/>
<person name="Campbell I.G."/>
<person name="Phillips W.A."/>
<person name="Robbie M."/>
<person name="Hannan R.D."/>
<person name="Pearson R.B."/>
</authorList>
<dbReference type="PubMed" id="17178867"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-1968"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="13949" last="13956">
<title>Kinetic mechanism of AKT/PKB enzyme family.</title>
<authorList>
<person name="Zhang X."/>
<person name="Zhang S."/>
<person name="Yamane H."/>
<person name="Wahl R."/>
<person name="Ali A."/>
<person name="Lofgren J.A."/>
<person name="Kendall R.L."/>
</authorList>
<dbReference type="PubMed" id="16540465"/>
<dbReference type="DOI" id="10.1074/jbc.M601384200"/>
</citation>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="FASEB J." volume="22" first="3264" last="3275">
<title>VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase.</title>
<authorList>
<person name="Wright G.L."/>
<person name="Maroulakou I.G."/>
<person name="Eldridge J."/>
<person name="Liby T.L."/>
<person name="Sridharan V."/>
<person name="Tsichlis P.N."/>
<person name="Muise-Helmericks R.C."/>
</authorList>
<dbReference type="PubMed" id="18524868"/>
<dbReference type="DOI" id="10.1096/fj.08-106468"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Dev. Cell" volume="17" first="800" last="810">
<title>The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt.</title>
<authorList>
<person name="Suizu F."/>
<person name="Hiramuki Y."/>
<person name="Okumura F."/>
<person name="Matsuda M."/>
<person name="Okumura A.J."/>
<person name="Hirata N."/>
<person name="Narita M."/>
<person name="Kohno T."/>
<person name="Yokota J."/>
<person name="Bohgaki M."/>
<person name="Obuse C."/>
<person name="Hatakeyama S."/>
<person name="Obata T."/>
<person name="Noguchi M."/>
</authorList>
<dbReference type="PubMed" id="20059950"/>
<dbReference type="DOI" id="10.1016/j.devcel.2009.09.007"/>
</citation>
<scope>UBIQUITINATION BY TTC3</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Science" volume="325" first="1134" last="1138">
<title>The E3 ligase TRAF6 regulates Akt ubiquitination and activation.</title>
<authorList>
<person name="Yang W.-L."/>
<person name="Wang J."/>
<person name="Chan C.-H."/>
<person name="Lee S.-W."/>
<person name="Campos A.D."/>
<person name="Lamothe B."/>
<person name="Hur L."/>
<person name="Grabiner B.C."/>
<person name="Lin X."/>
<person name="Darnay B.G."/>
<person name="Lin H.-K."/>
</authorList>
<dbReference type="PubMed" id="19713527"/>
<dbReference type="DOI" id="10.1126/science.1175065"/>
</citation>
<scope>INTERACTION WITH TRAF6</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Am. J. Physiol." volume="298" first="C580" last="C591">
<title>The Akt isoforms are present at distinct subcellular locations.</title>
<authorList>
<person name="Santi S.A."/>
<person name="Lee H."/>
</authorList>
<dbReference type="PubMed" id="20018949"/>
<dbReference type="DOI" id="10.1152/ajpcell.00375.2009"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Neuro-oncol." volume="12" first="221" last="232">
<title>Akt2 and Akt3 play a pivotal role in malignant gliomas.</title>
<authorList>
<person name="Mure H."/>
<person name="Matsuzaki K."/>
<person name="Kitazato K.T."/>
<person name="Mizobuchi Y."/>
<person name="Kuwayama K."/>
<person name="Kageji T."/>
<person name="Nagahiro S."/>
</authorList>
<dbReference type="PubMed" id="20167810"/>
<dbReference type="DOI" id="10.1093/neuonc/nop026"/>
</citation>
<scope>INVOLVEMENT IN TUMORS</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="J. Invest. Dermatol." volume="131" first="655" last="661">
<title>Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K/Akt3 and PKC-delta in normal human dermal fibroblasts.</title>
<authorList>
<person name="Moriya C."/>
<person name="Jinnin M."/>
<person name="Yamane K."/>
<person name="Maruo K."/>
<person name="Muchemwa F.C."/>
<person name="Igata T."/>
<person name="Makino T."/>
<person name="Fukushima S."/>
<person name="Ihn H."/>
</authorList>
<dbReference type="PubMed" id="21191416"/>
<dbReference type="DOI" id="10.1038/jid.2010.361"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="Cell. Signal." volume="23" first="1515" last="1527">
<title>Akt signalling in health and disease.</title>
<authorList>
<person name="Hers I."/>
<person name="Vincent E.E."/>
<person name="Tavare J.M."/>
</authorList>
<dbReference type="PubMed" id="21620960"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2011.05.004"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-447</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="28">
<citation type="submission" date="2009-12" db="PDB data bank">
<title>The crystal structure of the PH domain of human Akt3 protein kinase.</title>
<authorList>
<person name="Vollmar M."/>
<person name="Wang J."/>
<person name="Zhang Y."/>
<person name="Elkins J.M."/>
<person name="Burgess-Brown N."/>
<person name="Chaikuad A."/>
<person name="Pike A.C.W."/>
<person name="Von Delft F."/>
<person name="Bountra C."/>
<person name="Arrowsmith C.H."/>
<person name="Weigelt J."/>
<person name="Edwards A."/>
<person name="Knapp S."/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.46 ANGSTROMS) OF 1-118</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] ARG-171</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Br. J. Cancer" volume="99" first="1265" last="1268">
<title>A novel AKT3 mutation in melanoma tumours and cell lines.</title>
<authorList>
<person name="Davies M.A."/>
<person name="Stemke-Hale K."/>
<person name="Tellez C."/>
<person name="Calderone T.L."/>
<person name="Deng W."/>
<person name="Prieto V.G."/>
<person name="Lazar A.J."/>
<person name="Gershenwald J.E."/>
<person name="Mills G.B."/>
</authorList>
<dbReference type="PubMed" id="18813315"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6604637"/>
</citation>
<scope>VARIANT MELANOMA LYS-17</scope>
<scope>CHARACTERIZATION OF VARIANT MELANOMA LYS-17</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2012" name="Nat. Genet." volume="44" first="934" last="940">
<title>De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes.</title>
<authorList>
<person name="Riviere J.B."/>
<person name="Mirzaa G.M."/>
<person name="O'Roak B.J."/>
<person name="Beddaoui M."/>
<person name="Alcantara D."/>
<person name="Conway R.L."/>
<person name="St-Onge J."/>
<person name="Schwartzentruber J.A."/>
<person name="Gripp K.W."/>
<person name="Nikkel S.M."/>
<person name="Worthylake T."/>
<person name="Sullivan C.T."/>
<person name="Ward T.R."/>
<person name="Butler H.E."/>
<person name="Kramer N.A."/>
<person name="Albrecht B."/>
<person name="Armour C.M."/>
<person name="Armstrong L."/>
<person name="Caluseriu O."/>
<person name="Cytrynbaum C."/>
<person name="Drolet B.A."/>
<person name="Innes A.M."/>
<person name="Lauzon J.L."/>
<person name="Lin A.E."/>
<person name="Mancini G.M."/>
<person name="Meschino W.S."/>
<person name="Reggin J.D."/>
<person name="Saggar A.K."/>
<person name="Lerman-Sagie T."/>
<person name="Uyanik G."/>
<person name="Weksberg R."/>
<person name="Zirn B."/>
<person name="Beaulieu C.L."/>
<person name="Majewski J."/>
<person name="Bulman D.E."/>
<person name="O'Driscoll M."/>
<person name="Shendure J."/>
<person name="Graham J.M. Jr."/>
<person name="Boycott K.M."/>
<person name="Dobyns W.B."/>
</authorList>
<dbReference type="PubMed" id="22729224"/>
<dbReference type="DOI" id="10.1038/ng.2331"/>
</citation>
<scope>VARIANTS MPPH2 SER-229 AND TRP-465</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="Nat. Genet." volume="44" first="941" last="945">
<title>De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly.</title>
<authorList>
<person name="Lee J.H."/>
<person name="Huynh M."/>
<person name="Silhavy J.L."/>
<person name="Kim S."/>
<person name="Dixon-Salazar T."/>
<person name="Heiberg A."/>
<person name="Scott E."/>
<person name="Bafna V."/>
<person name="Hill K.J."/>
<person name="Collazo A."/>
<person name="Funari V."/>
<person name="Russ C."/>
<person name="Gabriel S.B."/>
<person name="Mathern G.W."/>
<person name="Gleeson J.G."/>
</authorList>
<dbReference type="PubMed" id="22729223"/>
<dbReference type="DOI" id="10.1038/ng.2329"/>
</citation>
<scope>VARIANT MPPH2 LYS-17</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2012" name="Neuron" volume="74" first="41" last="48">
<title>Somatic activation of AKT3 causes hemispheric developmental brain malformations.</title>
<authorList>
<person name="Poduri A."/>
<person name="Evrony G.D."/>
<person name="Cai X."/>
<person name="Elhosary P.C."/>
<person name="Beroukhim R."/>
<person name="Lehtinen M.K."/>
<person name="Hills L.B."/>
<person name="Heinzen E.L."/>
<person name="Hill A."/>
<person name="Hill R.S."/>
<person name="Barry B.J."/>
<person name="Bourgeois B.F."/>
<person name="Riviello J.J."/>
<person name="Barkovich A.J."/>
<person name="Black P.M."/>
<person name="Ligon K.L."/>
<person name="Walsh C.A."/>
</authorList>
<dbReference type="PubMed" id="22500628"/>
<dbReference type="DOI" id="10.1016/j.neuron.2012.03.010"/>
</citation>
<scope>VARIANT MPPH2 LYS-17</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Clin. Genet." volume="85" first="396" last="398">
<title>AKT3 and PIK3R2 mutations in two patients with megalencephaly-related syndromes: MCAP and MPPH.</title>
<authorList>
<person name="Nakamura K."/>
<person name="Kato M."/>
<person name="Tohyama J."/>
<person name="Shiohama T."/>
<person name="Hayasaka K."/>
<person name="Nishiyama K."/>
<person name="Kodera H."/>
<person name="Nakashima M."/>
<person name="Tsurusaki Y."/>
<person name="Miyake N."/>
<person name="Matsumoto N."/>
<person name="Saitsu H."/>
</authorList>
<dbReference type="PubMed" id="23745724"/>
<dbReference type="DOI" id="10.1111/cge.12188"/>
</citation>
<scope>VARIANT MPPH2 SER-229</scope>
</reference>
<comment type="function">
<text evidence="16 21">AKT3 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT3 is the least studied AKT isoform. It plays an important role in brain development and is crucial for the viability of malignant glioma cells. AKT3 isoform may also be the key molecule in up-regulation and down-regulation of MMP13 via IL13. Required for the coordination of mitochondrial biogenesis with growth factor-induced increases in cellular energy demands. Down-regulation by RNA interference reduces the expression of the phosphorylated form of BAD, resulting in the induction of caspase-dependent apoptosis.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="4">Two specific sites, one in the kinase domain (Thr-305) and the other in the C-terminal regulatory region (Ser-472), need to be phosphorylated for its full activation (By similarity). IGF-1 leads to the activation of AKT3, which may play a role in regulating cell survival.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="14">87.9 uM for ATP (for purified and in vitro activated AKT3)</KM>
<KM evidence="14">12.4 uM for peptide substrate (for purified and in vitro activated AKT3)</KM>
<KM evidence="14">118.7 uM for ATP (for recombinant myristoylated AKT3 expressed and immunoprecipitated from Rat-1 cells)</KM>
<KM evidence="14">2.3 uM for peptide substrate (for recombinant myristoylated AKT3 expressed and immunoprecipitated from Rat-1 cells)</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="5 11 12 18">Interacts (via PH domain) with TCL1A; this enhances AKT3 phosphorylation and activation. Interacts with TRAF6. Interacts with KCTD20 (By similarity). Interacts with BTBD10 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296115"/>
<interactant intactId="EBI-524064">
<id>P42574</id>
<label>CASP3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-296115"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Membrane</location>
<topology evidence="19">Peripheral membrane protein</topology>
</subcellularLocation>
<text>Membrane-associated after cell stimulation leading to its translocation.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q9Y243-1</id>
<name>1</name>
<name>PKB gamma</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q9Y243-2</id>
<name>2</name>
<name>PKB gamma 1</name>
<sequence type="described" ref="VSP_004947"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text>In adult tissues, it is highly expressed in brain, lung and kidney, but weakly in heart, testis and liver. In fetal tissues, it is highly expressed in heart, liver and brain and not at all in kidney.</text>
</comment>
<comment type="domain">
<text>Binding of the PH domain to the phosphatidylinositol 3-kinase alpha (PI(3)K) results in its targeting to the plasma membrane.</text>
</comment>
<comment type="PTM">
<text evidence="4">Phosphorylation on Thr-305 and Ser-472 is required for full activity.</text>
</comment>
<comment type="PTM">
<text evidence="13 20 26">Ubiquitinated. When fully phosphorylated and translocated into the nucleus, undergoes 'Lys-48'-polyubiquitination catalyzed by TTC3, leading to its degradation by the proteasome.</text>
</comment>
<comment type="PTM">
<text evidence="4">O-GlcNAcylation at Thr-302 and Thr-309 inhibits activating phosphorylation at Thr-305 via disrupting the interaction between AKT and PDK1.</text>
</comment>
<comment type="disease">
<text>AKT3 is a key modulator of several tumors like melanoma, glioma and ovarian cancer. Active AKT3 increases progressively during melanoma tumor progression with highest levels present in advanced-stage metastatic melanomas. Promotes melanoma tumorigenesis by decreasing apoptosis. Plays a key role in the genesis of ovarian cancers through modulation of G2/M phase transition. With AKT2, plays a pivotal role in the biology of glioblastoma.</text>
</comment>
<comment type="disease" evidence="22 23 24 25">
<disease id="DI-04183">
<name>Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2</name>
<acronym>MPPH2</acronym>
<description>A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome.</description>
<dbReference type="MIM" id="615937"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="30">Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. RAC subfamily.</text>
</comment>
<comment type="caution">
<text evidence="30">In light of strong homologies in the primary amino acid sequence, the 3 AKT kinases were long surmised to play redundant and overlapping roles. More recent studies has brought into question the redundancy within AKT kinase isoforms and instead pointed to isoform specific functions in different cellular events and diseases. AKT1 is more specifically involved in cellular survival pathways, by inhibiting apoptotic processes; whereas AKT2 is more specific for the insulin receptor signaling pathway. Moreover, while AKT1 and AKT2 are often implicated in many aspects of cellular transformation, the 2 isoforms act in a complementary opposing manner. The role of AKT3 is less clear, though it appears to be predominantly expressed in brain.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/AKT3ID615ch1q44.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EMBL" id="AF124141">
<property type="protein sequence ID" value="AAD29089.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF135794">
<property type="protein sequence ID" value="AAD24196.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF085234">
<property type="protein sequence ID" value="AAL40392.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ245709">
<property type="protein sequence ID" value="CAB53537.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL117525">
<property type="protein sequence ID" value="CAB55977.1"/>
<property type="status" value="ALT_TERM"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY005799">
<property type="protein sequence ID" value="AAF91073.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591721">
<property type="protein sequence ID" value="CAH71866.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC096539">
<property type="protein sequence ID" value="CAH71866.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL592151">
<property type="protein sequence ID" value="CAH71866.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662889">
<property type="protein sequence ID" value="CAH71866.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591721">
<property type="protein sequence ID" value="CAH71867.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC096539">
<property type="protein sequence ID" value="CAH71867.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL592151">
<property type="protein sequence ID" value="CAH71867.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662889">
<property type="protein sequence ID" value="CAH71867.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL592151">
<property type="protein sequence ID" value="CAH72891.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC096539">
<property type="protein sequence ID" value="CAH72891.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591721">
<property type="protein sequence ID" value="CAH72891.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662889">
<property type="protein sequence ID" value="CAH72891.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL592151">
<property type="protein sequence ID" value="CAH72892.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC096539">
<property type="protein sequence ID" value="CAH72892.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591721">
<property type="protein sequence ID" value="CAH72892.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662889">
<property type="protein sequence ID" value="CAH72892.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662889">
<property type="protein sequence ID" value="CAH73072.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC096539">
<property type="protein sequence ID" value="CAH73072.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591721">
<property type="protein sequence ID" value="CAH73072.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL592151">
<property type="protein sequence ID" value="CAH73072.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL662889">
<property type="protein sequence ID" value="CAH73073.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC096539">
<property type="protein sequence ID" value="CAH73073.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591721">
<property type="protein sequence ID" value="CAH73073.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL592151">
<property type="protein sequence ID" value="CAH73073.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471148">
<property type="protein sequence ID" value="EAW77093.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471148">
<property type="protein sequence ID" value="EAW77094.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC121154">
<property type="protein sequence ID" value="AAI21155.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31076.1">
<molecule id="Q9Y243-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS31077.1">
<molecule id="Q9Y243-1"/>
</dbReference>
<dbReference type="PIR" id="A59380">
<property type="entry name" value="A59380"/>
</dbReference>
<dbReference type="PIR" id="T17287">
<property type="entry name" value="T17287"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001193658.1">
<molecule id="Q9Y243-2"/>
<property type="nucleotide sequence ID" value="NM_001206729.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005456.1">
<molecule id="Q9Y243-1"/>
<property type="nucleotide sequence ID" value="NM_005465.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_859029.1">
<molecule id="Q9Y243-2"/>
<property type="nucleotide sequence ID" value="NM_181690.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005273051.1">
<molecule id="Q9Y243-1"/>
<property type="nucleotide sequence ID" value="XM_005272994.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005273052.1">
<molecule id="Q9Y243-1"/>
<property type="nucleotide sequence ID" value="XM_005272995.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.498292"/>
<dbReference type="PDB" id="2X18">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.46"/>
<property type="chains" value="A/B/C/D/E/F/G/H=1-118"/>
</dbReference>
<dbReference type="PDBsum" id="2X18"/>
<dbReference type="ProteinModelPortal" id="Q9Y243"/>
<dbReference type="SMR" id="Q9Y243"/>
<dbReference type="BioGrid" id="115318">
<property type="interactions" value="26"/>
</dbReference>
<dbReference type="DIP" id="DIP-32584N"/>
<dbReference type="IntAct" id="Q9Y243">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="MINT" id="MINT-222821"/>
<dbReference type="STRING" id="9606.ENSP00000263826"/>
<dbReference type="BindingDB" id="Q9Y243"/>
<dbReference type="ChEMBL" id="CHEMBL4816"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2286"/>
<dbReference type="iPTMnet" id="Q9Y243"/>
<dbReference type="PhosphoSitePlus" id="Q9Y243"/>
<dbReference type="BioMuta" id="AKT3"/>
<dbReference type="DMDM" id="12643943"/>
<dbReference type="PaxDb" id="Q9Y243"/>
<dbReference type="PeptideAtlas" id="Q9Y243"/>
<dbReference type="PRIDE" id="Q9Y243"/>
<dbReference type="DNASU" id="10000"/>
<dbReference type="Ensembl" id="ENST00000263826">
<molecule id="Q9Y243-1"/>
<property type="protein sequence ID" value="ENSP00000263826"/>
<property type="gene ID" value="ENSG00000117020"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000336199">
<molecule id="Q9Y243-2"/>
<property type="protein sequence ID" value="ENSP00000336943"/>
<property type="gene ID" value="ENSG00000117020"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000366539">
<molecule id="Q9Y243-1"/>
<property type="protein sequence ID" value="ENSP00000355497"/>
<property type="gene ID" value="ENSG00000117020"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000366540">
<molecule id="Q9Y243-2"/>
<property type="protein sequence ID" value="ENSP00000355498"/>
<property type="gene ID" value="ENSG00000117020"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000613395">
<molecule id="Q9Y243-2"/>
<property type="protein sequence ID" value="ENSP00000479922"/>
<property type="gene ID" value="ENSG00000275199"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000619536">
<molecule id="Q9Y243-2"/>
<property type="protein sequence ID" value="ENSP00000483054"/>
<property type="gene ID" value="ENSG00000275199"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000621586">
<molecule id="Q9Y243-1"/>
<property type="protein sequence ID" value="ENSP00000479081"/>
<property type="gene ID" value="ENSG00000275199"/>
</dbReference>
<dbReference type="GeneID" id="10000"/>
<dbReference type="KEGG" id="hsa:10000"/>
<dbReference type="UCSC" id="uc001hzz.2">
<molecule id="Q9Y243-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10000"/>
<dbReference type="DisGeNET" id="10000"/>
<dbReference type="GeneCards" id="AKT3"/>
<dbReference type="HGNC" id="HGNC:393">
<property type="gene designation" value="AKT3"/>
</dbReference>
<dbReference type="HPA" id="CAB013090"/>
<dbReference type="HPA" id="HPA026441"/>
<dbReference type="MalaCards" id="AKT3"/>
<dbReference type="MIM" id="611223">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615937">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q9Y243"/>
<dbReference type="OpenTargets" id="ENSG00000117020"/>
<dbReference type="Orphanet" id="99802">
<property type="disease" value="Hemimegalencephaly"/>
</dbReference>
<dbReference type="Orphanet" id="83473">
<property type="disease" value="Megalencephaly - polymicrogyria - postaxial polydactyly - hydrocephalus"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24686"/>
<dbReference type="eggNOG" id="KOG0598">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XNPH">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00860000133668"/>
<dbReference type="HOGENOM" id="HOG000233033"/>
<dbReference type="HOVERGEN" id="HBG108317"/>
<dbReference type="InParanoid" id="Q9Y243"/>
<dbReference type="KO" id="K04456"/>
<dbReference type="OMA" id="REYIKNW"/>
<dbReference type="OrthoDB" id="EOG091G06FF"/>
<dbReference type="PhylomeDB" id="Q9Y243"/>
<dbReference type="TreeFam" id="TF102004"/>
<dbReference type="BRENDA" id="2.7.11.1">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-111447">
<property type="pathway name" value="Activation of BAD and translocation to mitochondria"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-114604">
<property type="pathway name" value="GPVI-mediated activation cascade"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1257604">
<property type="pathway name" value="PIP3 activates AKT signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1358803">
<property type="pathway name" value="Downregulation of ERBB2:ERBB3 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198323">
<property type="pathway name" value="AKT phosphorylates targets in the cytosol"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-198693">
<property type="pathway name" value="AKT phosphorylates targets in the nucleus"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-199418">
<property type="pathway name" value="Negative regulation of the PI3K/AKT network"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-211163">
<property type="pathway name" value="AKT-mediated inactivation of FOXO1A"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389357">
<property type="pathway name" value="CD28 dependent PI3K/Akt signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-389513">
<property type="pathway name" value="CTLA4 inhibitory signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-392451">
<property type="pathway name" value="G beta:gamma signalling through PI3Kgamma"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218920">
<property type="pathway name" value="VEGFR2 mediated vascular permeability"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5628897">
<property type="pathway name" value="TP53 Regulates Metabolic Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674400">
<property type="pathway name" value="Constitutive Signaling by AKT1 E17K in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804757">
<property type="pathway name" value="Regulation of TP53 Degradation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804758">
<property type="pathway name" value="Regulation of TP53 Activity through Acetylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6804759">
<property type="pathway name" value="Regulation of TP53 Activity through Association with Co-factors"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69202">
<property type="pathway name" value="Cyclin E associated events during G1/S transition"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8876198">
<property type="pathway name" value="RAB GEFs exchange GTP for GDP on RABs"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q9Y243"/>
<dbReference type="SignaLink" id="Q9Y243"/>
<dbReference type="SIGNOR" id="Q9Y243"/>
<dbReference type="ChiTaRS" id="AKT3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="AKT3"/>
<dbReference type="GenomeRNAi" id="10000"/>
<dbReference type="PRO" id="PR:Q9Y243"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000117020"/>
<dbReference type="CleanEx" id="HS_AKT3"/>
<dbReference type="ExpressionAtlas" id="Q9Y243">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q9Y243">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048854">
<property type="term" value="P:brain morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048873">
<property type="term" value="P:homeostasis of number of cells within a tissue"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0000002">
<property type="term" value="P:mitochondrial genome maintenance"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045793">
<property type="term" value="P:positive regulation of cell size"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032008">
<property type="term" value="P:positive regulation of TOR signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="CDD" id="cd05593">
<property type="entry name" value="STKc_PKB_gamma"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.29.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000961">
<property type="entry name" value="AGC-kinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR034675">
<property type="entry name" value="Akt3"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011993">
<property type="entry name" value="PH_dom-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR001849">
<property type="entry name" value="PH_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR017892">
<property type="entry name" value="Pkinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00169">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00433">
<property type="entry name" value="Pkinase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00233">
<property type="entry name" value="PH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00133">
<property type="entry name" value="S_TK_X"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF50729">
<property type="entry name" value="SSF50729"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51285">
<property type="entry name" value="AGC_KINASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50003">
<property type="entry name" value="PH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="2">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="RAC-gamma serine/threonine-protein kinase" id="PRO_0000085611">
<location>
<begin position="2"/>
<end position="479"/>
</location>
</feature>
<feature type="domain" description="PH" evidence="6">
<location>
<begin position="5"/>
<end position="107"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="7">
<location>
<begin position="148"/>
<end position="405"/>
</location>
</feature>
<feature type="domain" description="AGC-kinase C-terminal">
<location>
<begin position="406"/>
<end position="479"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="7">
<location>
<begin position="154"/>
<end position="162"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="7 8">
<location>
<position position="271"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="7">
<location>
<position position="177"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="2">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by PDPK1" evidence="26">
<location>
<position position="305"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="3">
<location>
<position position="447"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKC/PRKCZ" evidence="13">
<location>
<position position="472"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) threonine" evidence="4">
<location>
<position position="302"/>
</location>
</feature>
<feature type="glycosylation site" description="O-linked (GlcNAc) threonine" evidence="4">
<location>
<position position="309"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="59"/>
<end position="76"/>
</location>
</feature>
<feature type="disulfide bond" evidence="4">
<location>
<begin position="293"/>
<end position="307"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_004947" evidence="27 28 29">
<original>YDEDGMDCMDNERRPHFPQFSYSASGRE</original>
<variation>CQQSDCGMLGNWKK</variation>
<location>
<begin position="452"/>
<end position="479"/>
</location>
</feature>
<feature type="sequence variant" description="In MPPH2 and melanoma; results in activation of AKT; dbSNP:rs397514606." id="VAR_065830" evidence="17 22 23">
<original>E</original>
<variation>K</variation>
<location>
<position position="17"/>
</location>
</feature>
<feature type="sequence variant" description="In a glioblastoma multiforme sample; somatic mutation." id="VAR_040358" evidence="15">
<original>G</original>
<variation>R</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="sequence variant" description="In MPPH2; dbSNP:rs397514605." id="VAR_069260" evidence="24 25">
<original>N</original>
<variation>S</variation>
<location>
<position position="229"/>
</location>
</feature>
<feature type="sequence variant" description="In MPPH2; disease phenotype overlaps with megalencephaly-capillary malformation syndrome; dbSNP:rs587776935." id="VAR_069261" evidence="24">
<original>R</original>
<variation>W</variation>
<location>
<position position="465"/>
</location>
</feature>
<feature type="mutagenesis site" description="No activation after pervanadate treatment." evidence="10">
<original>T</original>
<variation>A</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="mutagenesis site" description="2-fold increase of phosphorylation steady state level, no activation after pervanadate treatment." evidence="10">
<original>T</original>
<variation>D</variation>
<location>
<position position="305"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="10">
<original>T</original>
<variation>A</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect." evidence="10">
<original>T</original>
<variation>D</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="mutagenesis site" description="67% decrease of activity after pervanadate treatment." evidence="9">
<original>S</original>
<variation>A</variation>
<location>
<position position="472"/>
</location>
</feature>
<feature type="mutagenesis site" description="1.4-fold increase of phosphorylation steady state level, 50% decrease of activity after pervanadate treatment." evidence="9">
<original>S</original>
<variation>D</variation>
<location>
<position position="472"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AAI21155." ref="9" evidence="30">
<original>L</original>
<variation>R</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="6"/>
<end position="15"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="17"/>
<end position="30"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="33"/>
<end position="41"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="44"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="51"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="60"/>
<end position="64"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="71"/>
<end position="75"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="84"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="92"/>
<end position="113"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2X18"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250"/>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9WUA6"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00145"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10092583"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11387345"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11707444"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11839817"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12162751"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16540465"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18524868"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18813315"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19713527"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20018949"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20059950"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21191416"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22500628"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22729223"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22729224"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23745724"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9512493"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11230166"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11387345"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<sequence length="479" mass="55775" checksum="F08BDDE6502E78FB" modified="1999-11-01" version="1">
MSDVTIVKEGWVQKRGEYIKNWRPRYFLLKTDGSFIGYKEKPQDVDLPYPLNNFSVAKCQ
LMKTERPKPNTFIIRCLQWTTVIERTFHVDTPEEREEWTEAIQAVADRLQRQEEERMNCS
PTSQIDNIGEEEMDASTTHHKRKTMNDFDYLKLLGKGTFGKVILVREKASGKYYAMKILK
KEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE
RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA
ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM
EDIKFPRTLSSDAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFSGVNWQDVYDKKLVP
PFKPQVTSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRPHFPQFSYSASGRE
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>